{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:10:24Z","timestamp":1790007024301,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":194,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejpb.2021.02.012","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T02:58:52Z","timestamp":1614653932000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking"],"prefix":"10.1016","volume":"162","author":[{"given":"Andrea","family":"Conde Penedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"D\u00edaz Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxo","family":"Fern\u00e1ndez Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Gonz\u00e1lez Barcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Otero Espinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejpb.2021.02.012_b0005","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jfo.2013.05.004","article-title":"Keratoconus","volume":"36","author":"Fourni\u00e9","year":"2013","journal-title":"J. Fr. Ophtalmol."},{"issue":"5","key":"10.1016\/j.ejpb.2021.02.012_b0010","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcrs.2007.12.039","article-title":"Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: Long-term results","volume":"34","author":"Raiskup-Wolf","year":"2008","journal-title":"J. Cataract Refract. Surg."},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.012_b0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/01.icu.0000233954.86723.25","article-title":"Crosslinking treatment of progressive keratoconus: new hope","volume":"17","author":"Wollensak","year":"2006","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.012_b0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1442-9071.2010.02228.x","article-title":"Collagen cross-linking: a new treatment paradigm in corneal disease - a review","volume":"38","author":"Snibson","year":"2010","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.012_b0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40662-015-0030-6","article-title":"Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives","volume":"29","author":"Mastropasqua","year":"2015","journal-title":"Eye Vis."},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.012_b0030","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1167\/iovs.11-9385","article-title":"Photochemical kinetics of corneal cross-linking with riboflavin","volume":"53","author":"Kamaev","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2021.02.012_b0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0002-9394(02)02220-1","article-title":"Riboflavin\/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus","volume":"135","author":"Wollensak","year":"2003","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.012_b0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cxo.12020","article-title":"Current status of corneal collagen cross-linking for keratoconus: a review","volume":"96","author":"Chan","year":"2013","journal-title":"Clin Exp Optom."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.012_b0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1442-9071.2010.02228.x","article-title":"Collagen cross-linking: a new treatment paradigm in corneal disease \u2013 a review","volume":"38","author":"Snibson","year":"2010","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ejpb.2021.02.012_b0050","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/ICO.0000000000001912","article-title":"Corneal cross-linking: the science beyond the myths and misconceptions","volume":"38","author":"Rubinfeld","year":"2019","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ejpb.2021.02.012_b0055","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jcrs.2019.06.027","article-title":"Corneal crosslinking: Current protocols and clinical approach","volume":"45","author":"Beckman","year":"2019","journal-title":"J. Cataract Refract. Surg."},{"issue":"5","key":"10.1016\/j.ejpb.2021.02.012_b0060","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1590\/S0004-27492011000500008","article-title":"Effect of corneal epithelium on ultraviolet-A and riboflavin absorption","volume":"74","author":"Bott\u00f3s","year":"2011","journal-title":"Arq. Bras. Oftalmol."},{"issue":"11","key":"10.1016\/j.ejpb.2021.02.012_b0065","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood\u2013retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.012_b0070","first-page":"684","article-title":"Paracellular permeability of corneal and conjunctival epithelia","volume":"30","author":"Huang","year":"1989","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.012_b0075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.04.010","article-title":"Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye","volume":"531","author":"Loftsson","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.012_b0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10384-011-0008-4","article-title":"Effects of benzalkonium chloride on the ocular surface of the rabbit","volume":"55","author":"Kim","year":"2011","journal-title":"Jpn. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.ejpb.2021.02.012_b0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5301\/ejo.5000125","article-title":"Transepithelial corneal collagen crosslinking for keratoconus: qualitative investigation by in vivo HRT II confocal analysis","volume":"22","author":"Caporossi","year":"2012","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2021.02.012_b0090","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jcrs.2008.11.036","article-title":"Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement","volume":"35","author":"Wollensak","year":"2009","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2021.02.012_b0095","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ajo.2015.02.005","article-title":"Transepithelial versus epithelium-off corneal cross-linking for the treatment of progressive keratoconus: a randomized controlled trial","volume":"159","author":"Soeters","year":"2015","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.012_b0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2012.09.051","article-title":"Enhancement of corneal permeation of riboflavin-5\u2019-phosphate through vitamin E TPGS: a promising approach in corneal trans-epithelial cross linking treatment","volume":"440","author":"Ostacolo","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.012_b0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/ICO.0000000000002088","article-title":"Topography and pachymetry guided, rapid epi-on corneal cross-linking for keratoconus: 7-year study results","volume":"39","author":"Caruso","year":"2020","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.012_b0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcrs.2018.01.010","article-title":"Quantitative analysis of corneal stromal riboflavin concentration without epithelial removal","volume":"44","author":"Rubinfeld","year":"2018","journal-title":"J. Cataract Refract. Surg."},{"issue":"11","key":"10.1016\/j.ejpb.2021.02.012_b0115","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jcrs.2018.07.029","article-title":"Corneal crosslinking without epithelial removal","volume":"44","author":"Stulting","year":"2018","journal-title":"J. Cataract Refract. Surg."},{"issue":"10","key":"10.1016\/j.ejpb.2021.02.012_b0120","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.xphs.2017.05.022","article-title":"Delivery of riboflavin-5'-monophosphate into the cornea: can liposomes provide any enhancement effects?","volume":"106","author":"Kandzija","year":"2017","journal-title":"J. Pharml. Sci."},{"key":"10.1016\/j.ejpb.2021.02.012_b0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcis.2015.02.011","article-title":"Water-dilutable microemulsions for transepithelial ocular delivery of riboflavin phosphate","volume":"463","author":"Lidich","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2021.02.012_b0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.colsurfb.2018.09.063","article-title":"Potentiality of microemulsion systems in treatment of ophthalmic disorders: T Keratoconus and dry eye syndrome \u2013 in vivo study","volume":"173","author":"Lidich","year":"2019","journal-title":"Colloids Surf., B"},{"issue":"6","key":"10.1016\/j.ejpb.2021.02.012_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066408","article-title":"Corneal absorption of a new riboflavin-nanostructured system for transepithelial collagen cross-linking","volume":"8","author":"Bottos","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.012_b0140","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/mp3005963","article-title":"Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability","volume":"10","author":"Morrison","year":"2013","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.012_b0145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1167\/iovs.16-20813","article-title":"Biomechanical strengthening of the human cornea induced by nanoplatform-based transepithelial riboflavin\/UV-A corneal cross-linking","volume":"58","author":"Labate","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2021.02.012_b0150","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcrs.2017.03.026","article-title":"Assessment of stromal riboflavin concentration-depth profile in nanotechnology-based transepithelial corneal crosslinking","volume":"43","author":"Lombardo","year":"2017","journal-title":"J. Cataract Refract. Surg."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.012_b0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0939-6411(03)00161-9","article-title":"Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications","volume":"57","author":"Berger","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"11","key":"10.1016\/j.ejpb.2021.02.012_b0160","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/polym10111221","article-title":"strategies for improving ocular drug bioavailability and corneal wound healing with chitosan-based delivery systems","volume":"10","author":"Irimia","year":"2018","journal-title":"Polymers"},{"issue":"7","key":"10.1016\/j.ejpb.2021.02.012_b0165","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/jbm.a.34482","article-title":"Effect of chitosan\/riboflavin modification on resin\/dentin interface: spectroscopic and microscopic investigations","volume":"101A","author":"Daood","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejpb.2021.02.012_b0170","unstructured":"T. Higuchi, K.A. Connors, Phase-solubility techniques, in: Advances in analytical chemistry and instrumentation, Reilly In C. N., New York, 1965."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.012_b0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2012.06.055","article-title":"Cyclodextrins","volume":"453","author":"Kurkov","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.012_b0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2012.05.007","article-title":"Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes","volume":"47","author":"Loch","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.012_b0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000090726","article-title":"Glucose permeability of human, bovine, and porcine corneas in vitro","volume":"38","author":"Myung","year":"2006","journal-title":"Ophthalmic Res."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2021.02.012_b0190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2017.06.075","article-title":"Enhancement and inhibition effects on the corneal permeability of timolol maleate: polymers, cyclodextrins and chelating agents","volume":"529","author":"Rodr\u00edguez","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2021.02.012_b0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2014.06.007","article-title":"Enhancement in corneal permeability of riboflavin using calcium sequestering compounds","volume":"472","author":"Morrison","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.02.012_b0200","unstructured":"ECVAM DB-ALM: INVITTOX protocol (primero). Bovine Corneal Opacity and Permeability (BCOP) Assay INVITTOX no127, 2009."},{"key":"10.1016\/j.ejpb.2021.02.012_b0205","unstructured":"OECD. Test No. 437: bovine corneal opacity and permeability test method for identifying i) chemicals inducing serious eye damage and ii) chemicals not requiring classification for eye irritation or serious eye damage [Internet]. 2017. Available from: https:\/\/www.oecd-ilibrary.org\/content\/publication\/9789264203846-en."},{"issue":"6","key":"10.1016\/j.ejpb.2021.02.012_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198831","article-title":"Corneal epithelial permeability to fluorescein in humans by a multi-drop method","volume":"13","author":"Srinivas","year":"2018","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.012_b0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10561-013-9372-2","article-title":"A portable device for measuring donor corneal transparency in eye banks","volume":"15","author":"Parekh","year":"2014","journal-title":"Cell Tissue Bank"},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.012_b0220","first-page":"300","article-title":"An\u00e1lisis de la toxicidad ocular de los colirios de voriconazol y fluconazol con HET-CAM [Analysis of ocular toxicity of fluconazole and voriconazole eyedrops using HET-CAM]","volume":"38","author":"Fern\u00e1ndez-Ferreiro","year":"2014","journal-title":"Farm hosp."},{"issue":"5","key":"10.1016\/j.ejpb.2021.02.012_b0225","first-page":"363","article-title":"Drug permeation through biomembranes: cyclodextrins and the unstirred water layer","volume":"67","author":"Loftsson","year":"2012","journal-title":"Pharm"},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.012_b0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1600-0420.2002.800205.x","article-title":"Cyclodextrins in eye drop formulations: Enhanced topical delivery of corticosteroids to the eye","volume":"80","author":"Loftsson","year":"2002","journal-title":"Acta Ophthalmol. Scand."},{"issue":"9","key":"10.1016\/j.ejpb.2021.02.012_b0235","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/js960012b","article-title":"Effect of nicotinamide and urea on the solubility of riboflavin in various solvents","volume":"85","author":"Coffman","year":"1996","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2021.02.012_b0240","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/acs.molpharmaceut.7b00556","article-title":"Moustafine RI, Khutoryanskiy VV. Crown ethers: novel permeability enhancers for ocular drug delivery?","volume":"14","author":"Morrison","year":"2017","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2021.02.012_b0245","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.2042-7158.2012.01492.x","article-title":"Non-inclusion complexes between riboflavin and cyclodextrins","volume":"64","author":"de Jesus","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejpb.2021.02.012_b0250","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s10953-011-9724-0","article-title":"Inclusion complex formation between modified cyclodextrins and riboflavin and alloxazine in aqueous solution","volume":"40","author":"Terekhova","year":"2011","journal-title":"J Solut Chem."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.012_b0255","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10973-010-0858-x","article-title":"Thermodynamic study on inclusion complex formation of riboflavin with hydroxypropyl-\u03b2-cyclodextrin in water","volume":"101","author":"Zielenkiewicz","year":"2010","journal-title":"J. Therm. Anal. Calorim."},{"issue":"121","key":"10.1016\/j.ejpb.2021.02.012_b0260","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.carbpol.2014.11.017","article-title":"Inclusion complexes of chloramphenicol with \u03b2-cyclodextrin and aminoacids as a way to increase drug solubility and modulate ROS production","volume":"5","author":"Aiassa","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2021.02.012_b0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10847-016-0603-6","article-title":"Ternary complexation of benzoic acid with \u03b2-cyclodextrin and aminoacids. Experimental and theoretical studies","volume":"85","author":"M\u00e9ndez","year":"2016","journal-title":"J. Incl. Phenom. Macro"},{"issue":"9","key":"10.1016\/j.ejpb.2021.02.012_b0270","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.ejmech.2010.05.068","article-title":"Synthesis and characterization of binary and ternary complexes of diclofenac with a methyl-\u03b2-CD and monoethanolamine and in vitro transdermal evaluation","volume":"45","author":"Mora","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejpb.2021.02.012_b0275","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4155\/tde-2018-0028","article-title":"Binary and ternary complexes of norfloxacin to improve the solubility of the active pharmaceutical ingredient","volume":"9","author":"Ponce-Ponte","year":"2018","journal-title":"Ther. Deliv."},{"issue":"7","key":"10.1016\/j.ejpb.2021.02.012_b0280","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/pharmaceutics11070321","article-title":"Penetration enhancers in ocular drug delivery","volume":"11","author":"Moiseev","year":"2019","journal-title":"Pharmaceutics."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.012_b0285","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1167\/iovs.07-0993","article-title":"Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of pseudomonas aeruginosa keratitis","volume":"49","author":"Zaidi","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2021.02.012_b0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1432-1033.1989.tb15171.x","article-title":"Differential effects of \u03b1-, \u03b2- and \u03b3-cyclodextrins on human erythrocytes","volume":"186","author":"Ohtani","year":"1989","journal-title":"Eur. J. Biochem."},{"issue":"26","key":"10.1016\/j.ejpb.2021.02.012_b0295","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.biomaterials.2011.03.056","article-title":"Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening","volume":"32","author":"Yeh","year":"2011","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.012_b0300","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1248\/bpb.29.155","article-title":"Effects of poly-L-arginine on the permeation of hydrophilic compounds through surface ocular tissues","volume":"29","author":"Nemoto","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.ejpb.2021.02.012_b0305","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1248\/bpb.b15-00932","article-title":"Characterization of ocular iontophoretic drug transport of ionic and non-ionic compounds in isolated rabbit cornea and conjunctiva","volume":"39","author":"Sekijima","year":"2016","journal-title":"Biol. Pharm. Bull."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:40:58Z","timestamp":1760546458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":61,"alternative-id":["S0939641121000564"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.02.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}